Newsroom: Confluent Announces Significant Investment in ATI Nitinol Melt Expansion


Today Nitinol Devices & Components (“NDC”) launched a new corporate brand strategy that elevates the company’s corporate identity and underscores its unique abilities to support medical device manufacturers from concept generation to commercial scale production.

The new strategy emphasizes NDC’s specific capabilities and expertise in working with Nitinol-based devices for endovascular, peripheral vascular, cardiovascular, neurovascular and orthopedic applications and its commitment to technical excellence. It also hi-lights the company’s adaptability and flexibility in working with medical device manufacturers to meet ever-changing timelines and requirements.

NDC’s updated brand strategy signifies the growth and transformation of the company over the past years in response to customer needs.

About NDC

NDC is a technically-driven contract manufacturer of Nitinol-based medical devices headquartered in Fremont, CA, USA. NDC has a proven, 25-year track record of partnering with the medical device community and delivering high-quality Nitinol devices and components.


Latest News

March 8, 2024

Confluent Appoints Sandy Stojkovski and Brian Yoor to its Board of Directors

Read More ›
January 25, 2024

Confluent Announces Significant Investment in ATI Nitinol Melt Expansion

Read More ›
June 23, 2023

Confluent’s New Polymer Webshop Provides Solution to PTFE Lead Time Constraints

Read More ›

Partnering with you every step of the way

Contact Confluent Medical today and make sure your project is supported by our unmatched resources, technical expertise and proven service to meet any design, modification or manufacturing requirements.